SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 15.59 |
| Enterprise Value ($M) | 16.37 |
| Book Value ($M) | -0.85 |
| Book Value / Share | -0.04 |
| Price / Book | -18.33 |
| NCAV ($M) | -0.89 |
| NCAV / Share | -0.04 |
| Price / NCAV | -17.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -113.84 |
| Return on Assets (ROA) | -1.68 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.27 |
| Current Ratio | 0.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.40 |
| Assets | 0.44 |
| Liabilities | 1.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.23 |
| Operating Income | -0.46 |
| Net Income | -0.46 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.35 |
| Cash from Investing | -0.02 |
| Cash from Financing | 0.25 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| CBGL – Cannabis Global, Inc. | CDXI – Cardax, Inc. |
| CENBF – CEN Biotech, Inc. | CFRXQ – ContraFect Corporation |
| CHHE – China Health Industries Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io